Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Microbleeds and Genetic Risk Factors to Predict the Risk of Intracranial Haemorrhage in Patients Treated With Anticoagulation Following Cardioembolic Stroke Due to Atrial Fibrillation

NCT02513316 is registered in ClinicalTrials.gov with University College, London as lead sponsor.

NCT NCT02513316
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02513316 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Microbleeds and Genetic Risk Factors to Predict the Risk of Intracranial Haemorrhage in Patients Treated With Anticoagulation Following Cardioembolic Stroke Due to Atrial Fibrillation
Lead sponsor
University College, London
Phase
Observational
Overall status
Completed
Start date
August 4, 2011
Completion date
October 31, 2017
Enrollment
2,490 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation (af), intracerebral haemorrhage (ich), stroke